Cutaneous warts in patients with human immunodeficiency virus (HIV) are prevalent and respond poorly to conventional treatment. Recent studies suggest that highly active antiretroviral therapy (HAART) is associated with wart regression (unpublished data, November 2000).1 The purpose of this study was to determine whether immune reconstitution plays a role in the natural history of cutaneous warts in HIV-positive individuals.